Buscar resultados de ensayos clínicos
Pancreatic Neuroendocrine Tumor - 45 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET) Condición: Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours Fecha: 2014-09-23 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors Condición: Well-differentiated Pancreatic Neuroendocrine Tumor Fecha: 2012-01-13 Intervenciones: Drug: sunitinib Sunitinib capsules will be given orally at continuous daily dosing with a starting dose |
Recruiting |
Nombre del estudio: A Biological Prospective Study in Patients With Metastatic Pancreatic NETs Treated With Everolimus Condición: Pancreatic Neuroendocrine Tumour Metastatic Fecha: 2014-06-17 Intervenciones: Drug: Everolimus 10 mg daily everolimus is a recently approved mTOR inhibitor in advanced progressing we |
Recruiting |
Nombre del estudio: Observational Study In Real Life Settings Of The Systemic Treatment Of Well Differentiated, Unresectable Or Metastatic, Progressive Pancreatic Neuroendocrine Tumors (pNET): A Study Of Morbidity And Mortality At 2 Years Condición: Pancreatic Neuroendocrine Tumor, Well Differentiated and Progressive Fecha: 2014-09-02 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors Condición:
|
Active, not recruiting |
Nombre del estudio: Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine Tumors Condición: Non Functioning Pancreatic Endocrine Tumor Fecha: 2016-04-26 Intervenciones: Biological: Chromogranin A The plasma level of chromogranin A (CgA) was measured in enrolled patients wh |
Recruiting |
Nombre del estudio: Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery Condición:
|
Completed |
Nombre del estudio: Comparative Study of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neoplasms Condición: Pancreatic Neuroendocrine Tumors Fecha: 2014-04-26 Intervenciones:
|
Recruiting |
Nombre del estudio: Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China Condición: Pancreatic Neuroendocrine Tumors Fecha: 2016-06-16 Intervenciones: Drug: everolimus Everolimus is taken at a starting dose of 10 mg orally once daily.Patients will be prov |
Completed |
Nombre del estudio: An Analysis of Presentation and Outcome Following Treatment of Pancreatic Endocrine Neoplasms Condición: Pancreatic Endocrine Neoplasms Fecha: 2015-03-23 |